Articles by Suzanne Hodsden

  1. Oncology Alliance Launches First Human Trial for Leukemia Treatment 12/3/2014

    Oxford BioTherapeutics (OBT) and the Menarini Group are prepared to begin human trials for OBT357 (MEN1112), indicated for the treatment of acute myeloid leukemia (AML).

  2. Researchers: Vegetable Oil More Effective Than Antibiotics Against Gastric Bacteria 12/3/2014

    Researchers at the University of California, San Diego have developed a new treatment for gastric bacterial infections, a major cause of peptic ulcers and gastric cancer.

  3. Infection-Fighting Biosimilars Expected To Hit $1.8B By 2023 11/25/2014

    Decisions Resources Group (DRG) surveyed oncologists from France and Germany to gauge their opinion and preferences toward a wave of biosimilars which are poised to enter the market over the next few years.

  4. Tufts Report Puts Cost Of R&D At $2.6B Per New Drug 11/21/2014

    It’s not a secret that developing a safe and effective drug is a long, arduous, and expensive process. A new study released this week estimates the approximate numbers. According to Tufts Center for the Study of Drug Development, the cost of developing a new drug from discovery to market is about $2.6 billion and is over a decade’s worth of work.

  5. Merck JV, Hilleman Laboratories Form Collaboration To Fast-Track Oral Cholera Vaccine 11/20/2014

    Hilleman Laboratories, a vaccine developer and manufacturer based in New Delhi, has signed a Memorandum of Understanding (MoU) with ICD DR, B and Incepta Vaccine to expedite clinical trials and eventual marketing for a new oral cholera vaccine, Business Standard reports.

  6. Report: Global Initiatives To Improve Access To Medicine Show Both Strengths And Weaknesses 11/19/2014

    The Access to Medicine Index (AMI), a report published every two years by an independent initiative based in the Netherlands, ranks top pharmaceutical companies (18 total) based on their efforts to promote better and more global access to medicine.

  7. GNS Healthcare, CHDI Foundation Renew Huntington's Disease Research Collaboration 11/17/2014

    In order to speed efforts toward effective treatments, GNS Healthcare and the CHDI Foundation are continuing their collaboration to research potential genomic and molecular targets to treat Huntington’s disease.

  8. Milk: A Novel Delivery System For Pediatric HIV Drugs 11/14/2014

    Scientists at Penn State have developed a method of altering proteins in milk so that they bind with antiretroviral drugs. 

  9. Gonorrhea Joins List Of Increasingly Antibiotic-Resistant Infections 11/13/2014

    Public Health England released a report which found that gonorrhea was building resistance to traditional antibiotic treatment, The Pharmaceutical Journal reports.

  10. Cancer Innovation Coalition Seeks To Close Gap Between Development And Market 10/30/2014

    The Cancer Innovation Coalition (CIC) convened its first national policy forum this week where researchers, government officials, and industry experts met to discuss methods of closing the gap between promising new therapies and cancer patients, Drug Discovery and Development (DDD) reports.